Welcome to the PRESTIGE-AF project. PRESTIGE-AF is a 6,9 million euro project to optimise stroke prevention in patients with intracerebral haemorrhage.

PRESTIGE-AF Study: 23 Participants
Predictive Modelling of Risk Substudy:  11 Participants
Pharmacology Substudy: 3 Participant
Longitudinal Neuroimaging Substudy: 1 Participant

Sites with recruitment: 12

5 Participants:
– Site 101 Imperial College Healthcare NHS Trust- UK

3 Participants:
– Site 202: Alfried Krupp Krankenhaus Rüttenscheid, Essen- Germany
– Site 405 Hospital Dr Josep Trueta, Girona- Spain

2 Participants:
– Site 112 Northumbria Healthcare NHS Foundation Trust- UK
– Site 406: Hospital Universitario Virgen Macarena- Spain

1 Participant:
– Site 106 Hull and East Yorkshire NHS Trust- UK
– Site 105 Mid Yorkshire Hospitals NHS Trust-UK
– Site 210 Klinikum Altenburgerland- Germany
– Site 218 Universitätsklinikum Tübingen Neurologie- German
– Site 301 Medical University Graz- Austria
– Site 411 Germans Trias I Pujol Hospital Barcelona- Spain
– Site 214 Minden- Germany
– Site 215 Leipzig- Germany

For more information about PRESTIGE-AF clinical trials and patient eligibility, contact us.